Zobrazeno 1 - 10
of 140
pro vyhledávání: '"Laura, Spring"'
Autor:
Emily J. Gallagher, Heather Moore, Mario E. Lacouture, Susan F. Dent, Azeez Farooki, Marcus D. Goncalves, Claudine Isaacs, Abigail Johnston, Dejan Juric, Zoe Quandt, Laura Spring, Brian Berman, Melanie Decker, Gabriel N. Hortobagyi, Benjamin H. Kaffenberger, Bernice Y. Kwong, Timothy Pluard, Ruta Rao, Lee Schwartzberg, Michael S. Broder
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-11 (2024)
Abstract Hyperglycemia and rash are expected but challenging adverse events of phosphatidylinositol-3-kinase inhibition (such as with alpelisib). Two modified Delphi panels were conducted to provide consensus recommendations for managing hyperglycemi
Externí odkaz:
https://doaj.org/article/8183fb8cce4340f9881e7c5f5b6eef4c
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/48889d017f334e9c8e416ed708a32860
Autor:
Elizabeth K. O'Donnell, Yael N. Shapiro, Amy Comander, Steven J. Isakoff, Beverly Moy, Laura Spring, Seth Wander, Irene Kuter, Jennifer Shin, Jerry Younger, Michelle Specht, Chryssanthi Kourniotis, Carol Sullivan, Loren Winters, Nora Horick, Jeffrey Peppercorn
Publikováno v:
Cancer Research. 82:PD5-11
Background: Prior, retrospective analysis of nightly fasting among women with breast cancer suggests that fasting less than 13 hours per night may be associated with higher risk of breast cancer recurrence. Small studies suggest that fasting duration
Autor:
Ming Shan, Laura Spring, Minetta C Liu, Erika Hamilton, Hanna Irie, Cesar A Santa-Maria, Steven J Isakoff, James Reeves, Leif W Ellisen, Lee P Lim, Kavita Garg, Caterina Bertucci, Bin Feng, Hailei Zhang, Kaiming Sun, Julie R Graham, Erin Hofstatter, Hyo Han
Publikováno v:
Cancer Research. 82:P5-13
Background: Survival advantages with neoadjuvant chemotherapy (NACT) have been observed in patients (pts) with locally advanced breast cancer (BC) who achieve pathological complete response (pCR). Predicting risk of early recurrence in pts without pC
Autor:
Steven J Isakoff, Eva Glieberman, Maya Said, Agnes H. Kwak, Emily A. O’Rourke, Amanda Stroiney, Laura Spring, Beverly Moy, Aditya Bardia, Nora Horick, Jeffrey Peppercorn
Publikováno v:
Cancer Research. 82:P4-12
Background: Patients’ understanding of their breast cancer (BC) diagnosis is important in improving treatment adherence, shared decision-making, and clinical trial matching. However, studies have reported discrepancies between electronic medical re
Autor:
Steven J Isakoff, Nadine M. Tung, Jun Yin, Nabihah Tayob, Joanne Parker, Julie Rosenberg, Aditya Bardia, Laura Spring, Hannah Park, Maya Collins, William T. Barry, Mariano Severgnini, Doris Peterkin, Sara M. Tolaney
Publikováno v:
Cancer Research. 82:P2-14
Background: Immunotherapy with checkpoint inhibition is active in mTNBC. Both pembrolizumab and atezolizumab are FDA approved for programmed cell death ligand 1 positive (PDL1+) mTNBC. Vaccines may further induce host immune response and enhance ther
Autor:
Trenton Reinicke, Justin F. Gainor, Marissa N Bruno, Henning Willers, Erika Nakajima, Anand S. Dighe, Yi-Bin Chen, Vivek Naranbhai, Leyre Zubiri, Aleigha Lawless, Brittany Y Bertaux, Aditya Bardia, Kerry L. Reynolds, Rebecca R. Saff, Jocelyn R. Farmer, Kerri St. Denis, A. John Iafrate, Elizabeth Niehoff, Joan How, Mustafa Sakhi, Grace Kirkpatrick, Arthur Y. Kim, Wilfredo-Garcia Beltran, Alejandro B. Balazs, Alexander Gavralidis, Caroline Barabell, Monica A Jackson, C. Bowes, Lailoo A Perriello, Amir T. Fathi, Andrew M. Brunner, Evan C. Lam, Gabriela S. Hobbs, Grace Hambelton, Christian N Nambu, Kimberly G. Blumenthal, Julia Thierauf, Laura Spring, Elyssa Denault, Claire A. Pernat, Steven J. Isakoff, Ryan J. Sullivan, Cristhian J Berrios-Mairena, Jennifer L Peterson, Lindsey Mortensen, Onosereme Ofoman
Publikováno v:
Journal of Clinical Oncology. 40:12-23
PURPOSE The immunogenicity and reactogenicity of SARS-CoV-2 vaccines in patients with cancer are poorly understood. METHODS We performed a prospective cohort study of adults with solid-organ or hematologic cancers to evaluate anti–SARS-CoV-2 immuno
Autor:
Aditya Bardia, Leif W. Ellisen, Beverly Moy, Jerry Younger, Steven Isakoff, Dejan Juric, Laura Spring, Seth A. Wander, A. John Iafrate, Jochen Lennerz, Megan Yuen, Giuliana Malvarosa, Andrzej Niemierko, Neelima Vidula
Supplemental Table S2. Characteristics of patients who underwent both cfDNA and tumor tissue genotyping testing.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fd42cff408953cad140a061429de071
https://doi.org/10.1158/1078-0432.22478591.v1
https://doi.org/10.1158/1078-0432.22478591.v1
Autor:
Aditya Bardia, Leif W. Ellisen, Beverly Moy, Jerry Younger, Steven Isakoff, Dejan Juric, Laura Spring, Seth A. Wander, A. John Iafrate, Jochen Lennerz, Megan Yuen, Giuliana Malvarosa, Andrzej Niemierko, Neelima Vidula
Supplemental Figure S1. Consort diagram of patients included in this study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2998564aa59f4e2763604d0c55929f90
https://doi.org/10.1158/1078-0432.22478597.v1
https://doi.org/10.1158/1078-0432.22478597.v1
Autor:
Aditya Bardia, Daniel A. Haber, Shyamala Maheswaran, Leif W. Ellisen, Lee Zou, Gad Getz, A. John Iafrate, Mehmet Toner, Richard Lanman, Jerry Younger, Kristen Shannon, Beverly Moy, Laura Spring, Seth Wander, Douglas Micalizzi, Dejan Juric, Steven J. Isakoff, Jochen Lennerz, Giuliana Malvarosa, Brittany A. Reeves, Brian Chirn, Whijae Roh, Becky Nagy, Erica Blouch, Andrzej Niemierko, Antoine Simoneau, Michael S. Lawrence, Taronish Dubash, Neelima Vidula
Supplemental tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45f8f984938202d81f8bb40c208e5d2c
https://doi.org/10.1158/1078-0432.22475513.v1
https://doi.org/10.1158/1078-0432.22475513.v1